NeoGenomics Inc (NEO) income statement
NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3025% below fair value
$15.29+0.04 (+0.26%)
Close on Nov 18, 2026Market cap $1.98BP/E –Yield –
NeoGenomics Inc income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 44.8%
- Operating margin
- -6.3%
- Net margin
- -4.1%
- Return on equity, FY2025
- -12.4%
Financial strength
- Current ratio
- 3.53
- Debt to equity
- 0.47
- Debt to assets
- 27.2%
- Cash to current liabilities
- 119.9%
Valuation
- P/E ratio
- –
- Price to sales
- 2.51
- Price to book
- 2.47
- Dividend yield
- –
See a number that looks wrong?